Guan Chao Holdings Limited has announced that its wholly owned subsidiary, BetaMind Investments Limited, has entered into three definitive agreements. These include a Trademark License Agreement, a Lizi Exclusive Authorisation Agreement, and a Jingtai Exclusive Authorisation Agreement. These agreements, effective from May 26, 2025, involve research, development, and commercialization rights related to the compounds XTP-016 and XTP-118. These compounds are crucial for formulating hair growth products, with XTP-118 intended for second-generation product development. The agreements signify a strategic advancement in Guan Chao Holdings' business operations, focusing on enhancing their product offerings in the hair growth market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.